Literature DB >> 32519391

Novel insights regarding anaphylaxis in children - With a focus on prevalence, diagnosis, and treatment.

Ken-Ichi Nagakura1,2, Sakura Sato3,4, Tomoyuki Asaumi1, Noriyuki Yanagida1, Motohiro Ebisawa2,3.   

Abstract

Anaphylaxis is a serious allergic reaction that occurs rapidly and causes a life-threatening response involving the whole body. This reaction often leads to difficulty in breathing and can result in death. The estimated prevalence of anaphylaxis is 0.05%-2%, which is reported to be increasing in children. Although drugs and venom are the most common causes of anaphylaxis in adults, food is the most common cause of anaphylaxis in children. An interesting association between food-dependent exercise-induced anaphylaxis (FDEIA) and oral immunotherapy (OIT) has recently been reported. A provocation test to determine the diagnostic and augmenting factors of FDEIA has been reported in recent years. Remarkably, several articles showed allergic symptoms without exercise in children with FDEIA and in those with FDEIA development after OIT. Regarding OIT, full-dose OIT poses a risk of adverse reactions, including anaphylaxis. Recent trials have shown the efficacy and safety of low-dose OIT in patients with food-induced anaphylaxis. In this review, we summarized the novel insights regarding anaphylaxis in the pediatric population.
© 2020 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.

Entities:  

Keywords:  anaphylaxis; augmenting factor; children; food allergy; food-dependent exercise-induced anaphylaxis; low dose; oral immunotherapy; pediatric population

Year:  2020        PMID: 32519391     DOI: 10.1111/pai.13307

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN: 0905-6157            Impact factor:   6.377


  2 in total

Review 1.  Recent advances in diagnosing and managing nut allergies with focus on hazelnuts, walnuts, and cashew nuts.

Authors:  Magnus P Borres; Sakura Sato; Motohiro Ebisawa
Journal:  World Allergy Organ J       Date:  2022-04-11       Impact factor: 5.516

Review 2.  The 2020 update on anaphylaxis in paediatric population.

Authors:  Izabela Tarczoń; Ewa Cichocka-Jarosz; Anna Knapp; Przemko Kwinta
Journal:  Postepy Dermatol Alergol       Date:  2021-02-06       Impact factor: 1.837

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.